Ambroxol hydrochloride(2-amino-3,5-dibromo-N-methylbenzylamine hydrochloride)has been used as a mucolytic agent in the treatment of respiratory diseases since the late 1970s.Its effects on mucus membranes such as mucu...Ambroxol hydrochloride(2-amino-3,5-dibromo-N-methylbenzylamine hydrochloride)has been used as a mucolytic agent in the treatment of respiratory diseases since the late 1970s.Its effects on mucus membranes such as mucus disruption,increased mucus production,and low toxicity profile were addressed in its original German patent in 1966.These first described properties have kept Ambroxol available worldwide and over the counter in the pharmaceutical market to this day.展开更多
目的观察小儿消积止咳口服液治疗儿童慢性咳嗽的疗效及机制。方法选取慢性咳嗽患儿110例,随机分为对照组与观察组,每组55例。对照组患儿给予常规治疗,观察组患儿在常规治疗的基础上给予小儿消积止咳口服液治疗。另选取同期健康体检儿童5...目的观察小儿消积止咳口服液治疗儿童慢性咳嗽的疗效及机制。方法选取慢性咳嗽患儿110例,随机分为对照组与观察组,每组55例。对照组患儿给予常规治疗,观察组患儿在常规治疗的基础上给予小儿消积止咳口服液治疗。另选取同期健康体检儿童55例作为健康组。比较观察组与对照组的疗效,治疗前后评估咳嗽评分及匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI),检测治疗前后外周血嗜酸性粒细胞(eosinophils,EOS)、降钙素原(procalcitonin,PCT)、肿瘤坏死因子-α(tumor necrosisfactor-α,TNF-α)、干扰素-γ(interferon-γ,IFN-γ)、白细胞介素(interleukins,IL)-4(IL-4)、IL-8以及免疫球蛋白(immunoglobulin,Ig)A、IgG和IgM水平,检测肺功能包括用力肺活量(forced vital capacity,FVC)、第1秒用力呼气量百分比(the percentage of forced expiratory volume in the first second,FEV_(1)%)和呼气峰值流速(peak expiratory flow rate,PEF)。结果观察组的总有效率高于对照组,体温复常时间、肺啰音消失时间、咳痰消失时间及咳嗽消失时间均较对照组缩短,治疗后咳嗽评分及PSQI评分均低于对照组(P<0.05)。观察组和对照组治疗前的外周血EOS、PCT、TNF-α、IL-4和IL-8水平均高于健康组,IFN-γ、IgA、IgG和IgM水平均低于健康组(P<0.05);治疗后,观察组和对照组的外周血EOS、PCT、TNF-α、IL-4和IL-8水平均降低,IFN-γ、IgA、IgG和IgM水平均降低,FVC、FEV_(1)%和PEF均升高,且观察组上述指标均明显优于对照组(P<0.05)。结论外周血EOS、PCT、TNF-α、IL-4和IL-8水平在儿童慢性咳嗽中明显升高,IFN-γ水平明显降低,采用小儿消积止咳口服液治疗能够调节上述各指标平衡,提高临床疗效并促进症状缓解。展开更多
基金partly funded by the Clinician-Scientist grant(No.472-0-0)by the medical faculty of the University of Tübingen(to SCV).
文摘Ambroxol hydrochloride(2-amino-3,5-dibromo-N-methylbenzylamine hydrochloride)has been used as a mucolytic agent in the treatment of respiratory diseases since the late 1970s.Its effects on mucus membranes such as mucus disruption,increased mucus production,and low toxicity profile were addressed in its original German patent in 1966.These first described properties have kept Ambroxol available worldwide and over the counter in the pharmaceutical market to this day.
文摘目的观察小儿消积止咳口服液治疗儿童慢性咳嗽的疗效及机制。方法选取慢性咳嗽患儿110例,随机分为对照组与观察组,每组55例。对照组患儿给予常规治疗,观察组患儿在常规治疗的基础上给予小儿消积止咳口服液治疗。另选取同期健康体检儿童55例作为健康组。比较观察组与对照组的疗效,治疗前后评估咳嗽评分及匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI),检测治疗前后外周血嗜酸性粒细胞(eosinophils,EOS)、降钙素原(procalcitonin,PCT)、肿瘤坏死因子-α(tumor necrosisfactor-α,TNF-α)、干扰素-γ(interferon-γ,IFN-γ)、白细胞介素(interleukins,IL)-4(IL-4)、IL-8以及免疫球蛋白(immunoglobulin,Ig)A、IgG和IgM水平,检测肺功能包括用力肺活量(forced vital capacity,FVC)、第1秒用力呼气量百分比(the percentage of forced expiratory volume in the first second,FEV_(1)%)和呼气峰值流速(peak expiratory flow rate,PEF)。结果观察组的总有效率高于对照组,体温复常时间、肺啰音消失时间、咳痰消失时间及咳嗽消失时间均较对照组缩短,治疗后咳嗽评分及PSQI评分均低于对照组(P<0.05)。观察组和对照组治疗前的外周血EOS、PCT、TNF-α、IL-4和IL-8水平均高于健康组,IFN-γ、IgA、IgG和IgM水平均低于健康组(P<0.05);治疗后,观察组和对照组的外周血EOS、PCT、TNF-α、IL-4和IL-8水平均降低,IFN-γ、IgA、IgG和IgM水平均降低,FVC、FEV_(1)%和PEF均升高,且观察组上述指标均明显优于对照组(P<0.05)。结论外周血EOS、PCT、TNF-α、IL-4和IL-8水平在儿童慢性咳嗽中明显升高,IFN-γ水平明显降低,采用小儿消积止咳口服液治疗能够调节上述各指标平衡,提高临床疗效并促进症状缓解。